Ocular Complications of Severe Vernal Keratoconjunctivitis (VKS ) in Nangarhar Province Afghanistan
DOI:
https://doi.org/10.53555/bp.v5i7.1041Keywords:
Cataract, Glaucoma, Keratoconus, Visual impairment, vernal keratoconjuctivitisAbstract
VKC is a potentially severe, chronic, allergic condition, causing bilateral recurrent inflammatory disorder of the conjunctiva and cornea.
The aim of this study was to assess the ocular complications and visual loss among patients with severe vernal keratoconjunctivitis (VKS).
Material and Methods 481 patients with VKC seen at Department of Ophthalmology Nangerhar university teaching hospital were the study group. This is a retrospective none – comparative observational study between 30/06/2018 and 30/06/2019. Visual acuity was measured with the standard Snellen chart and for children less than 5 years of age Kay pictures were used. Visual impairment was assessed by means of the world health organization criteria, for visual disabilities. Cases with severe VKC that developed ocular complications leading to blindness and severe visual impairment were analyzed.
At the Results the majority of VKC patients were males (75.9%). A total of 76 (15.8%) patients (60 boys and 16 girls) had severe VKC. the ocular findings among 20 patients with severe VKC that led to blindness and severe visual impairment included keratoconus (7) steroid – induced cataract (5) central corneal scars (5) and steroid induced glaucoma (3) two of the keratoconus cases developed acute hydrops.
Downloads
References
Boniin, S., Lamiase, A, sgrutela, R., Bonini, S. (2003). Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis. Curr, open allergy clin . immunol. 3(5), 381-387.
Bonini, S; Coassin, M, Aronni, s; Lambiase, A. (2004) vernal keratoconjunctivitis eye, 18,345-351.
Bremond Gignac, D. Donadieu, A; Leonardi, A; Pouliquen, P, Doan, S, chiambarretta, F, et al, 2008. Prevalence of vernal keratoconjunctivitis: A rare disease? Br. J. Ophthalmol. 92, 1097-1102.
Farouk, S, Al-Tal, A., Bamashmus, M, Haider, T., (2005). prevalence of allergic eye diseases in Kuwait university Hospital, Sana’a, Yemen. Presented in the first Yemeni-Saudi conference of clinical immunology, Sana’a, May 25 – 26, 2005.
Gupta, v., Sahu, P.K, (2001). Topical Cyclosporine A in the Management of Vernal keratoconjunctivitiseye, 15, 39 – 41.
Iqbal, A., Jan, S., babar , TF; Khan, M.D. (2003) Corneal Complication of Vernal Catarrh.J. coll. Physicians surg.pak. 13(7) , 394-397.
Kosrirukvongs, P, Visitsunthorn, N., Vichyanond, P., Bunnag, C. (2001). Allergic conjunctivitis. Asian Pac. J. allergy Immunol. 19, 237 – 244.
Kosrirukongs p., vichyanond, Wongsawad, W., (2003) vernal keratoconjunctivitis in Thailand . Asian Pac. J. Allergy immunol. 21, 25 – 30.
Kumar, S. (2009). vernal keratoconjunctivitis : a major review. Acta ophthalmol. Scand. 87, 133 – 147.
Lambiase , A; Minchiotti S; Leonardi, A; Secchi, AG; Rolando m; Calabria, G, et al, (2009) . Prospective, multicenter demographic and Epidemiological study on vernal keratoconjunctivitis: a Glimpse of ocular surface in Italian population. Ophthalmic epidermal. 16, 38 – 41.
Lenoardi, A. (2002). vernal keratoconjunctivitis : pathogenesis and treatment . Prog . Ret eye res. 21, 319 – 339.
Leonardi, a; Secchi, A.G. (2003) vernal keratoconjunctivitis. Inter. Ophthalmol . Clin. 43, 41 – 58.
Leonardi, A., Busca, F., Motterle, L., Cavarzeran, F., Frgona, I.A., Plebani, m., et a,., (2006), case series of 406 vernal keratoconjunctivitis patients : a demographic and epidemiological study. Acta ophthalmol . Scand . 84,406-410.
Tabbara, K.F., (1999). Ocular complications of vernal keratoconjunctivitis. Can. J. ophthalmol. 34(2), 88 – 92.
Totan, Y., Hepsen, I.F., Cekic, O., Gundus, A., Aydin, E., (2001). Incidence of keratoconus in subjects with vernal keratoconjunctivitis: a videokertographic study. Phthalmology 108,824-827.
Ukponmwan, C.U., (2003). Vernal keratoconjunctivitis in Nigerians: 109 consecutive cases. Trop. Doct. 33,242 – 245.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 International Journal For Research In Biology & Pharmacy (ISSN: 2208-2093)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.
By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in